MLKL and neurodegenerative disease: The identification and clinical description of additional human individuals that are homozygous or compound heterozygous for MLKL LOF alleles will shed further light on whether the absence of MLKL alone is sufficient to give rise to neurodegenerative disease, or if other genetic or environmental events are indeed at play.